- Home
- SGML vs BCRX Comparison
SGML vs BCRX Comparison
Compare SGML & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGML
- BCRX
- Stock Information
- Founded
- SGML 2011
- BCRX 1986
- Country
- SGML Brazil
- BCRX United States
- Employees
- SGML N/A
- BCRX N/A
- Industry
- SGML Industrial Machinery/Components
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SGML Industrials
- BCRX Health Care
- Exchange
- SGML Nasdaq
- BCRX Nasdaq
- Market Cap
- SGML 1.5B
- BCRX 1.7B
- IPO Year
- SGML N/A
- BCRX 1994
- Fundamental
- Price
- SGML $13.95
- BCRX $7.60
- Analyst Decision
- SGML Strong Buy
- BCRX Strong Buy
- Analyst Count
- SGML 2
- BCRX 5
- Target Price
- SGML $24.50
- BCRX $15.60
- AVG Volume (30 Days)
- SGML 790.9K
- BCRX 2.5M
- Earning Date
- SGML 11-15-2024
- BCRX 11-04-2024
- Dividend Yield
- SGML N/A
- BCRX N/A
- EPS Growth
- SGML N/A
- BCRX N/A
- EPS
- SGML N/A
- BCRX N/A
- Revenue
- SGML $142,748,436.00
- BCRX $412,579,000.00
- Revenue This Year
- SGML $45.28
- BCRX $37.24
- Revenue Next Year
- SGML $90.35
- BCRX $19.30
- P/E Ratio
- SGML N/A
- BCRX N/A
- Revenue Growth
- SGML 48.43
- BCRX 29.92
- 52 Week Low
- SGML $8.47
- BCRX $4.03
- 52 Week High
- SGML $34.31
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- SGML 52.60
- BCRX 50.10
- Support Level
- SGML $11.39
- BCRX $7.02
- Resistance Level
- SGML $14.71
- BCRX $8.25
- Average True Range (ATR)
- SGML 1.00
- BCRX 0.40
- MACD
- SGML 0.04
- BCRX -0.03
- Stochastic Oscillator
- SGML 75.74
- BCRX 51.13
About SGML Sigma Lithium Corporation
Sigma Lithium Corp is dedicated to powering the next generation of electric vehicle batteries with environmentally sustainable and high-purity lithium. The company is in construction at its wholly owned Grota do Cirilo Project in Brazil, one of the highest-grade hard rock lithium spodumene deposits in the Americas.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.